Search
for
Sort by
Research 751–780 of 1000+
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
- Attempted construction of minoxidil: carboxylic acid cocrystals; 7 salts and 1 cocrystal resulted
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- An update of anti-viral treatment of COVID-19
- Coronavirus and Obesity: Could Insulin Resistance Mediate the Severity of Covid-19 Infection?
- A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
- Recurrence of cutaneous T‐cell lymphoma post viral vector COVID‐19 vaccination
- Clinical characteristics and outcomes of adult patients admitted with COVID-19 in East London: a retrospective cohort analysis
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Changes in dermatological complaints among healthcare professionals during the COVID-19 outbreak in Turkey
- Roles of existing drug and drug targets for COVID-19 management
- A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)
- Comparative analysis of long-term self-reported COVID-19 symptoms among pregnant women
- Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
- Expression of concern: potential risk for developing severe COVID-19 disease among anabolic steroid users
- Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Pityriasis rosea as a leading manifestation of COVID‐19 infection
- Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us?
- Detection of Male Hypogonadism in Patients with Post COVID-19 Condition
- The effect of canakinumab on clinical outcomes in patients with COVID-19: A meta-analysis
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
- Opportunistic pathogenic fungal co-infections are prevalent in critically ill COVID-19 patients: Are they risk factors for disease severity?